Skip to main content
. 2014 Nov 12;32(12):2488–2498. doi: 10.1097/HJH.0000000000000331

FIGURE 4.

FIGURE 4

The mean change in SBP and DBP (+SD), and control and response rates from baseline to Week 8 for patients of different race who received treatment with placebo, candesartan cilexetil, nifedipine GITS or nifedipine GITS-candesartan cilexetil combination (n = 1332). SD, standard deviation. aThirty patients were of other racial origins.